about
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where ...
Read More
1.98
0.05
(2.59%)
84,603
XNAS Volume
XNAS 02 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Entera Bio Ltd is on 05 Sep 2025 for the purpose of Entera Bio Ltd. H.C. Wainwright Conference 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Entera Bio Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..